Big Sioux Wealth Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
Other funds holding IBRX
Big Sioux Wealth Management's IBRX Position: Q3 2026 in Review
Big Sioux Wealth Management increased its ImmunityBio (IBRX) stake by 4% in Q3 2026, buying an estimated $44.4K and bringing the position to 143,587 shares worth $1.36M. The position accounts for 0.65% of the portfolio, ranked #25.
Big Sioux Wealth Management first reported a position in IBRX in Q4 2025 and has held it in 4 quarters since. 407 funds tracked by Wall St. Rank hold IBRX as of Q3 2026.
- Big Sioux Wealth Management held 143,587 shares of ImmunityBio worth $1.36M as of Q3 2026.
- Big Sioux Wealth Management bought 5,560 ImmunityBio shares in Q3 2026, an estimated $44.4K.
- ImmunityBio made up 0.65% of Big Sioux Wealth Management's portfolio in Q3 2026, its #25 holding.
- Big Sioux Wealth Management first reported a position in ImmunityBio in Q4 2025 and has held it in 4 quarters since.
- 407 funds tracked by Wall St. Rank held ImmunityBio as of Q3 2026.
Based on Big Sioux Wealth Management's 13F filing for Q3 2026, filed 19 Nov 2026.